Cases & Deals

Implanet completes IPO on NYSE Euronext Paris

Clients Implanet SA

Jones Day represented Implanet SA, a medical technology company producing state-of-the-art implants used in orthopaedic surgery, in connection with the issuance of €14.1 million (US$19.4 million) of New Shares in an initial public offering on the NYSE Euronext Paris.